Featurespace expands global fraud and financial crime expertise with addition of industry veteran

Featurespace expands global fraud and financial crime expertise with addition of industry veteran

Featurespace, the world-leader in fraud detection, risk prevention and Anti-Money Laundering monitoring, announced the addition of Dena Hamilton as the company's newest Fraud and Financial Crime market expert.

Círculo de Crédito and Featurespace partner to innovate the fight against application fraud in Mexico

Círculo de Crédito and Featurespace partner to innovate the fight against application fraud in Mexico

Featurespace, the world-leader in fraud detection and risk prevention, and Círculo de Crédito, a leading credit bureau in Latin America, have announced a partnership that will introduce the ARIC™ platform to Mexico, bringing a more effective defense against application fraud to lenders in the market.

Dr Ramsey Faragher wins outstanding achievement accolade by industry experts

Dr Ramsey Faragher wins outstanding achievement accolade by industry experts

On Friday 20th 2019 at the annual GPS World Dinner held at the Institute of Navigation GNSS+ Conference, Dr Ramsey Faragher, Founder & CEO of Focal Point Positioning was presented with the prestigious GPS World signals leadership award for their groundbreaking SuperCorrelation technology.

Dosing complete in Phase I clinical trial of ultra-rapid acting insulin product candidate for diabetes

Dosing complete in Phase I clinical trial of ultra-rapid acting insulin product candidate for diabetes

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces completion of dosing and all patient visits in its Phase I clinical trial for its ultra-rapid acting insulin product candidate, AT247.

ICR Collaborates With AI Drug Discovery Company To Develop Treatments for Rare Childhood Cancer

ICR Collaborates With AI Drug Discovery Company To Develop Treatments for Rare Childhood Cancer

Scientists at The Institute of Cancer Research, London, are working with Healx, a biotech company specialising in artificial intelligence (AI) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), an essentially untreatable brain cancer in children.

Kheiron’s $22 million Series A funds early breast cancer detection for women worldwide

Kheiron’s $22 million Series A funds early breast cancer detection for women worldwide

Kheiron Medical Technologies, an applied science company focused on innovating cancer diagnostics through machine learning, announced a $22 million Series A round led by Atomico with participation from existing investors Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds.

Fico and Arachnys forge compliance partnership

Fico and Arachnys forge compliance partnership

FICO, a leading analytics software firm and provider of financial crime compliance solutions, today announced a partnership with Arachnys, a leader in risk investigation solutions for client onboarding, Know Your Customer (KYC), customer due diligence & enhanced due diligence (CDD/EDD), and anti-money laundering (AML).

Repositive appoints new Head of Strategic Growth and leading commercial advisers to drive scale-up

Repositive appoints new Head of Strategic Growth and leading commercial advisers to drive scale-up

Repositive – the Cambridge-based startup that connects researchers with the right preclinical cancer models for their research – today announced the appointment of Slaven Stekovic as Head of Strategic Growth, along with leading commercial experts (Mariana Vaschetto and Francesca Crawford) to its advisory board, to drive the company’s scale-up and global growth ambitions within the pharma and biotech market.